Literature DB >> 17389742

Positive correlation of pigment epithelium-derived factor and total antioxidant capacity in aqueous humour of patients with uveitis and proliferative diabetic retinopathy.

Yumiko Yoshida1, Sho-ichi Yamagishi, Takanori Matsui, Kazuo Nakamura, Tsutomu Imaizumi, Koichi Yoshimura, Ryoji Yamakawa.   

Abstract

BACKGROUND/AIMS: There are several animal studies to suggest that pigment epithelium-derived factor (PEDF) may exert beneficial effects on diabetic retinopathy and uveitis by acting as an endogenous antioxidant. However, the interrelationship between PEDF and total antioxidant capacity in the human eye remains to be elucidated. In this study, PEDF and total antioxidant levels were determined in the aqueous humour of patients with proliferative diabetic retinopathy (PDR) and uveitis, and the relationship between these two markers was investigated.
METHODS: Aqueous humour levels of PEDF and total antioxidant capacity were determined by an ELISA system in 34 uveitis and 9 PDR samples.
RESULTS: Aqueous humour levels of PEDF and total antioxidant capacity were significantly lower in patients with PDR than those with uveitis (1.8+/-0.2 microg/ml vs 6.4+/-0.8 microg/ml and 0.17+/-0.03 mmol/l vs 0.85+/-0.05 mmol/l, respectively, p<0.01). A positive correlation between PEDF and total antioxidant capacity was found in patients with PDR and uveitis (r = 0.33, p<0.05).
CONCLUSION: This study demonstrated that PEDF levels were associated with total antioxidant capacity in aqueous humour levels in humans. These observations suggest that substitution of PEDF may be a therapeutic target for oxidative stress-involved eye diseases, especially PDR.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17389742      PMCID: PMC1954896          DOI: 10.1136/bjo.2007.115188

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  17 in total

1.  Increased levels of pigment epithelium-derived factor in aqueous humor of patients with uveitis.

Authors:  Yumiko Yoshida; Sho-Ichi Yamagishi; Takanori Matsui; Kazuo Nakamura; Tsutomu Imaizumi; Koichi Yoshimura; Ryoji Yamakawa
Journal:  Br J Ophthalmol       Date:  2006-09-14       Impact factor: 4.638

2.  Increased serum concentrations of pigment epithelium-derived factor in patients with end-stage renal disease.

Authors:  Yoshihiro Motomiya; Sho-Ichi Yamagishi; Hisashi Adachi; Akio Abe
Journal:  Clin Chem       Date:  2006-10       Impact factor: 8.327

3.  Low content of the natural ocular anti-angiogenic agent pigment epithelium-derived factor (PEDF) in aqueous humor predicts progression of diabetic retinopathy.

Authors:  B O Boehm; G Lang; O Volpert; P M Jehle; A Kurkhaus; S Rosinger; G K Lang; N Bouck
Journal:  Diabetologia       Date:  2003-03-01       Impact factor: 10.122

4.  Pigment epithelial growth factor suppresses inflammation by modulating macrophage activation.

Authors:  Parisa Zamiri; Sharmila Masli; J Wayne Streilein; Andrew W Taylor
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-09       Impact factor: 4.799

5.  Loss of the antiangiogenic pigment epithelium-derived factor in patients with angiogenic eye disease.

Authors:  J Spranger; M Osterhoff; M Reimann; M Möhlig; M Ristow; M K Francis; V Cristofalo; H P Hammes; G Smith; M Boulton; A F Pfeiffer
Journal:  Diabetes       Date:  2001-12       Impact factor: 9.461

6.  Pigment epithelium-derived factor suppresses ischemia-induced retinal neovascularization and VEGF-induced migration and growth.

Authors:  Elia J Duh; Hoseong S Yang; Izumi Suzuma; Masaru Miyagi; Elaine Youngman; Keisuke Mori; Miyuki Katai; Lin Yan; Kiyoshi Suzuma; Karen West; Shekar Davarya; Patrick Tong; Peter Gehlbach; Joel Pearlman; John W Crabb; Lloyd P Aiello; Peter A Campochiaro; Donald J Zack
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-03       Impact factor: 4.799

7.  Pigment epithelium-derived factor in the vitreous is low in diabetic retinopathy and high in rhegmatogenous retinal detachment.

Authors:  N Ogata; J Tombran-Tink; M Nishikawa; T Nishimura; Y Mitsuma; T Sakamoto; M Matsumura
Journal:  Am J Ophthalmol       Date:  2001-09       Impact factor: 5.258

8.  Pigment epithelium-derived factor inhibits advanced glycation end product-induced retinal vascular hyperpermeability by blocking reactive oxygen species-mediated vascular endothelial growth factor expression.

Authors:  Sho-ichi Yamagishi; Kazuo Nakamura; Takanori Matsui; Yosuke Inagaki; Katsuhiko Takenaka; Yuko Jinnouchi; Yumiko Yoshida; Tetsuro Matsuura; Isao Narama; Yoshihiro Motomiya; Masayoshi Takeuchi; Hiroyoshi Inoue; Akihiko Yoshimura; Richard Bucala; Tsutomu Imaizumi
Journal:  J Biol Chem       Date:  2006-05-17       Impact factor: 5.157

9.  Positive correlation between pigment epithelium-derived factor and monocyte chemoattractant protein-1 levels in the aqueous humour of patients with uveitis.

Authors:  Yumiko Yoshida; Sho-Ichi Yamagishi; Takanori Matsui; Kazuo Nakamura; Tsutomu Imaizumi; Koichi Yoshimura; Ryoji Yamakawa
Journal:  Br J Ophthalmol       Date:  2006-12-13       Impact factor: 4.638

10.  Elevated serum levels of pigment epithelium-derived factor in the metabolic syndrome.

Authors:  Sho-Ichi Yamagishi; Hisashi Adachi; Akio Abe; Takako Yashiro; Mika Enomoto; Kumiko Furuki; Asuka Hino; Yuko Jinnouchi; Katsuhiko Takenaka; Takanori Matsui; Kazuo Nakamura; Tsutomu Imaizumi
Journal:  J Clin Endocrinol Metab       Date:  2006-03-07       Impact factor: 5.958

View more
  11 in total

1.  Changes of total antioxidant capacity and total oxidant status of aqueous humor in diabetes patients and correlations with diabetic retinopathy.

Authors:  Emrullah Beyazyıldız; Ali Bülent Cankaya; Esra Ergan; Mustafa Alparslan Anayol; Yasemin Ozdamar; Sevilay Sezer; Mehmet Hakan Tırhış; Pelin Yılmazbaş; Faruk Oztürk
Journal:  Int J Ophthalmol       Date:  2013-08-18       Impact factor: 1.779

2.  Involvement of TAGE-RAGE System in the Pathogenesis of Diabetic Retinopathy.

Authors:  Masayoshi Takeuchi; Jun-Ichi Takino; Sho-Ichi Yamagishi
Journal:  J Ophthalmol       Date:  2010-06-22       Impact factor: 1.909

3.  Potential therapeutic effects of pigment epithelium-derived factor for treatment of diabetic retinopathy.

Authors:  Xiao Liu; Hui-Hui Chen; Li-Wei Zhang
Journal:  Int J Ophthalmol       Date:  2013-04-18       Impact factor: 1.779

4.  Levels of thrombopoietin in aqueous humor of patients with noninfectious acute anterior uveitis.

Authors:  José-Juan Mondejar; David Salom; Salvador Garcia-Delpech; Manuel Diaz-Llopis
Journal:  Clin Ophthalmol       Date:  2015-07-13

Review 5.  PEDF and its roles in physiological and pathological conditions: implication in diabetic and hypoxia-induced angiogenic diseases.

Authors:  Xuemin He; Rui Cheng; Siribhinya Benyajati; Jian-xing Ma
Journal:  Clin Sci (Lond)       Date:  2015-06       Impact factor: 6.124

Review 6.  Future therapies of wet age-related macular degeneration.

Authors:  Makoto Ishikawa; Daisuke Jin; Yu Sawada; Sanae Abe; Takeshi Yoshitomi
Journal:  J Ophthalmol       Date:  2015-02-24       Impact factor: 1.909

7.  Proteomic analysis of human aqueous humor using multidimensional protein identification technology.

Authors:  Matthew R Richardson; Marianne O Price; Francis W Price; Jennifer C Pardo; Juan C Grandin; Jinsam You; Mu Wang; Mervin C Yoder
Journal:  Mol Vis       Date:  2009-12-11       Impact factor: 2.367

8.  Ratio of the vitreous vascular endothelial growth factor and pigment epithelial-derived factor in Eales disease.

Authors:  Narayanasamy Angayarkanni; Radhakrishnan Selvi; Rishi Pukhraj; Jyotirmoy Biswas; Shah J Bhavesh; Joyce Tombran-Tink
Journal:  J Ocul Biol Dis Infor       Date:  2009-03-06

9.  PEDF-Mediated Mitophagy Triggers the Visual Cycle by Enhancing Mitochondrial Functions in a H2O2-Injured Rat Model.

Authors:  Jae Yeon Kim; Sohae Park; Hee Jung Park; Se Ho Kim; Helen Lew; Gi Jin Kim
Journal:  Cells       Date:  2021-05-06       Impact factor: 6.600

10.  PEDF in diabetic retinopathy: a protective effect of oxidative stress.

Authors:  Xiao-feng Zhu; Hai-dong Zou
Journal:  J Biomed Biotechnol       Date:  2012-04-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.